The transaction, slated to close in the third quarter, is not expected to have an impact on the company’s 2016 sales or earnings forecasts.
Category archives: Johnson & Johnson
Johnson & Johnson Ordered to Pay $55 Million in Talc-Powder Trial
The company had lost a previous trial and faces approximately 1,200 lawsuits accusing it of not adequately warning consumers about its talc-based products’ cancer risks.